NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (OTCBB: BONU), a chemical technology-based Life Science company that intends to commercialize a novel combinational chemistry-based technology, today announced that the Company has appointed Dr. Donald Goldmann, M.D. to the Scientific Advisory Board. BioNeutral Group will be focusing its attention in areas which Dr. Goldmann has considerable expertise including hospital borne infections and bio-preparedness.
